作者:Steven T. Staben、Michael Siu、Richard Goldsmith、Alan G. Olivero、Steven Do、Daniel J. Burdick、Timothy P. Heffron、Jenna Dotson、Daniel P. Sutherlin、Bing-Yan Zhu、Vickie Tsui、Hoa Le、Leslie Lee、John Lesnick、Cristina Lewis、Jeremy M. Murray、Jim Nonomiya、Jodie Pang、Wei Wei Prior、Laurent Salphati、Lionel Rouge、Deepak Sampath、Steve Sideris、Christian Wiesmann、Ping Wu
DOI:10.1016/j.bmcl.2011.04.124
日期:2011.7
Starting from thienobenzopyran HTS hit 1, co-crystallization, molecular modeling and metabolic analysis were used to design potent and metabolically stable inhibitors of PI3-kinase. Compound 15 demonstrated PI3K pathway suppression in a mouse MCF7 xenograft model. (C) 2011 Elsevier Ltd. All rights reserved.